GARG PUSHKAL (CMO & EVP Dev & Med Affairs) sold 13.0% of their position (3.49K shares) of ALNYLAM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.13M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+4.77K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−50.00
Price / share
$323.62
Trade value
$16.18K
% of position
Common Stock
Shares
−97.00
Price / share
$324.65
Trade value
$31.49K
% of position
Common Stock
Shares
−277.00
Price / share
$325.63
Trade value
$90.20K
% of position
Common Stock
Shares
−421.00
Price / share
$326.81
Trade value
$137.59K
% of position
Common Stock
Shares
−353.00
Price / share
$327.67
Trade value
$115.67K
% of position
Common Stock
Shares
−107.00
Price / share
$328.71
Trade value
$35.17K
% of position
Common Stock
Shares
−182.00
Price / share
$329.71
Trade value
$60.01K
% of position
Common Stock
Shares
−87.00
Price / share
$330.85
Trade value
$28.78K
% of position
Common Stock
Shares
−101.00
Price / share
$331.93
Trade value
$33.52K
% of position
Common Stock
Shares
−42.00
Price / share
$332.64
Trade value
$13.97K
% of position
Common Stock
Shares
−355.00
Price / share
$316.74
Trade value
$112.44K
% of position
Common Stock
Shares
−317.00
Price / share
$319.06
Trade value
$101.14K
% of position
Common Stock
Shares
−640.00
Price / share
$320.48
Trade value
$205.11K
% of position
Common Stock
Shares
−463.00
Price / share
$321.50
Trade value
$148.85K
% of position
Net shares
+1.28K
Net value
-$1.13M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +4.77K | — | — | 21.6% | 22.13K | 26.90K |
| Common Stock Direct | 3/2/2026 | S · Sale | −50.00 | $323.62 | $16.18K | 0.2% | 26.90K | 26.85K |
| Common Stock Direct | 3/2/2026 | S · Sale | −97.00 | $324.65 | $31.49K | 0.4% | 26.85K | 26.75K |
| Common Stock Direct | 3/2/2026 | S · Sale | −277.00 | $325.63 | $90.20K | 1.0% | 26.75K | 26.47K |
| Common Stock Direct | 3/2/2026 | S · Sale | −421.00 | $326.81 | $137.59K | 1.6% | 26.47K | 26.05K |
| Common Stock Direct | 3/2/2026 | S · Sale | −353.00 | $327.67 | $115.67K | 1.4% | 26.05K | 25.70K |
| Common Stock Direct | 3/2/2026 | S · Sale | −107.00 | $328.71 | $35.17K | 0.4% | 25.70K | 25.59K |
| Common Stock Direct | 3/2/2026 | S · Sale | −182.00 | $329.71 | $60.01K | 0.7% | 25.59K | 25.41K |
| Common Stock Direct | 3/2/2026 | S · Sale | −87.00 | $330.85 | $28.78K | 0.3% | 25.41K | 25.32K |
| Common Stock Direct | 3/2/2026 | S · Sale | −101.00 | $331.93 | $33.52K | 0.4% | 25.32K | 25.22K |
| Common Stock Direct | 3/2/2026 | S · Sale | −42.00 | $332.64 | $13.97K | 0.2% | 25.22K | 25.18K |
| Common Stock Direct | 3/3/2026 | S · Sale | −355.00 | $316.74 | $112.44K | 1.4% | 25.18K | 24.83K |
| Common Stock Direct | 3/3/2026 | S · Sale | −317.00 | $319.06 | $101.14K | 1.3% | 24.83K | 24.51K |
| Common Stock Direct | 3/3/2026 | S · Sale | −640.00 | $320.48 | $205.11K | 2.6% | 24.51K | 23.87K |
| Common Stock Direct | 3/3/2026 | S · Sale | −463.00 | $321.50 | $148.85K | 1.9% | 23.87K | 23.41K |
| Total | +1.28K | -$1.13M | ||||||
Stock Option (right to buy)
Common Stock
10.48K shares
Shares
+10.48K
Strike price
325.07
Held after
10.48K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10.48K shares | 3/2/2026 | A · Award | +10.48K | 325.07 | — | 10.48K |
Common Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 431.00 | Indirect |
| Common Stock | 250.00 | Indirect |
| Total | 681.00 | 681.00 indirect |